Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-22,702
Closed -$77.2K 1094
2024
Q2
$77.2K Buy
22,702
+12,604
+125% +$41.2K ﹤0.01% 1032
2024
Q1
$30.6K Sell
10,098
-486
-5% -$1.71K ﹤0.01% 1066
2023
Q4
$44.6K Buy
+10,584
New +$57.4K ﹤0.01% 1070
2023
Q2
Sell
-40,483
Closed -$282K 1103
2023
Q1
$282K Buy
40,483
+1,715
+4% +$15K ﹤0.01% 899
2022
Q4
$234K Buy
38,768
+11,495
+42% +$84.9K ﹤0.01% 950
2022
Q3
$215K Buy
27,273
+9,300
+52% +$108K ﹤0.01% 927
2022
Q2
$245K Sell
17,973
-1,438
-7% -$23.8K ﹤0.01% 887
2022
Q1
$381K Buy
19,411
+702
+4% +$14K ﹤0.01% 866
2021
Q4
$642K Sell
18,709
-20,020
-52% -$805K 0.01% 758
2021
Q3
$2.12M Buy
38,729
+17,931
+86% +$1.08M 0.02% 434
2021
Q2
$1.53M Buy
+20,798
New +$2.08M 0.01% 504

Other funds holding CVAC

Vontobel Holding's CVAC Position: Q3 2024 in Review

Vontobel Holding sold out of CureVac (CVAC) in Q3 2024, closing a stake of 22,702 shares — an estimated $77.2K sold.

Vontobel Holding first reported a position in CVAC in Q2 2021 and held it in 11 quarters. The position peaked at $2.12M in Q3 2021. 81 funds tracked by Wall St. Rank hold CVAC as of Q3 2024.

  • Vontobel Holding reported no remaining CureVac position as of Q3 2024 after selling out during the quarter.
  • Vontobel Holding sold 22,702 CureVac shares in Q3 2024, an estimated $77.2K.
  • Vontobel Holding first reported a position in CureVac in Q2 2021 and held it in 11 quarters.
  • Vontobel Holding's CureVac position peaked at $2.12M in Q3 2021.
  • 81 funds tracked by Wall St. Rank held CureVac as of Q3 2024.

Based on Vontobel Holding's 13F filing for Q3 2024, filed 16 Oct 2024.